Latest research report on “Pneumococcal Vaccine Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5561154
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
This report contains market size and forecasts of Pneumococcal Vaccine in global, including the following market information:
Global Pneumococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pneumococcal Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Pneumococcal Vaccine companies in 2021 (%)
The global Pneumococcal Vaccine market was valued at 7408.6 million in 2021 and is projected to reach US$ 7972.1 million by 2028, at a CAGR of 1.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PPSV 23 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Pneumococcal Vaccine Market Segment Percentages, by Type, 2021 (%)
– PPSV 23
– PCV 7/13
– PCV 10
Global Pneumococcal Vaccine Market, by End User, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Pneumococcal Vaccine Market Segment Percentages, by End User, 2021 (%)
– Child
– Adult
Global Pneumococcal Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Pneumococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pneumococcal Vaccine revenues share in global market, 2021 (%)
Key companies Pneumococcal Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Pneumococcal Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Pfizer
– GSK
– MSD
– Sanofipasteur
– CDIBP
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5561154
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441